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ABSTRACT 
Peroxisome  proliferation  has  been  induced  with  2-methyl-2-(p-[l,2,3,4-tetrahy- 
dro- l-naphthyl]-phenoxy)-propionic acid  (Su-13437).  DNA,  protein, cytochrome 
oxidase,  glucose-6-phosphatase,  and  acid  phosphatase  concentrations remain  al- 
most  constant.  Peroxisomal  enzyme  activities  change  to  approximately  165%, 
50%  30%  and 0%  of the controls for catalase, urate oxidase,  L-a-hydroxy acid 
oxidase, and D-amino acid oxidase,  respectively. For catalase  the change results 
from a decrease in particle-bound activity and a fivefold increase in soluble activ- 
ity. The average diameter of peroxisome sections is 0.58  •  0.15 tzm in controls 
and  0.73  •  0.25  ~tm  after treatment.  Therefore, the  measured  peroxisomal en- 
zymes are highly diluted in proliferated particles. 
After tissue  fractionation,  approximately one-half of the  normal  peroxisomes 
and all proliferated peroxisomes show matric extraction with ghost formation, but 
no  change  in  size.  In  homogenates  submitted  to  mechanical  stress,  proliferated 
peroxisomes do  not  reveal increased  fragility; unexpectedly, Su-13437  stabilizes 
lysosomes. Our  results  suggest  that  matrix extraction  and  increased  soluble en- 
zyme activities result from transmembrane passage of peroxisomal proteins. 
The changes in concentration of peroxisomal oxidases and soluble catalase after 
Su-13437  allow  the  calculation  of their  half-lives. These  are  the  same  as  those 
found for total catalase, in normal and treated rats, after allyl isopropyl acetamide: 
about  1.3 days, a result compatible with peroxisome degradation by autophagy. A 
sequential  increase  in  liver  RNA  concentration,  [l~C]leucine  incorporation into 
DOC-soluble  proteins and  into  immunoprecipitable catalase,  and  an  increase in 
liver size and peroxisomal volume per gram  liver, characterize the trophic effect 
of the drug used.  In males, Su-13437 is more active than CPIB,  another peroxi- 
some proliferation-inducing drug; in females, only Su-13437 is active. 
Peroxisomes are cell organelles,  widely distributed 
in  eucaryotic  cells,  whose  function  is  partially 
known only in protists (48) and plants (6, 29, 59). 
Their role in animal tissues  is not known, in spite 
of the  various  physical,  morphological, and  bio- 
chemical analyses  to  which  they have  been  sub- 
jected (2,  16,  31, 42,  43).  Most of the work has 
concentrated on rat liver peroxisomes, but their set 
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precise or unique place in metabolism.  Moreover, 
their  reduced  response  to  multiple  physiological 
and  pathological  conditions  (31,  57,  58) gives  no 
indication of to which cell function they might be 
related.  In fact, peroxisomes have been considered 
as  fossil  organelles  in  animal tissues  (15).  If that 
were  so,  they  would  constitute  expensive  fossils 
since they account for 2.5% of the liver protein and 
have a  high turnover rate that has been confirmed 
in  the present  work  (43,  52),  The hypothesis thus 
remains a  challenge to cell biologists. 
The induction of proliferation of peroxisomes by 
some drugs constitutes an exception to their appar- 
ent  inertness in the cell and  is a  potential tool for 
exploring  their function.  Particularly  active are  a 
group  of  hypolipidemic  drugs  that  induce  liver 
growth  in  rats;  and  some  of them  inhibit auxin- 
promoted  growth  in  plants  (I). p-Chlorophenoxy 
isobutyrate (CPIB) 1 has been the most widely used 
(25,  58).  Several  years  ago  we  selected  Su-13437, 
another drug from the group, to study peroxisome 
proliferation,  with  the  aim  of  establishing  the 
temporal course of the early changes and facilitat- 
ing  in  this way  the correlation  between  increased 
peroxisomal  mass  and  its  eventual  physiological 
activities. 
Su-13437  proved to be more active than CPIB, 
not  only  in  this  respect  but  also  as  an  antiauxin 
(39), as well as with respect to its known effect on 
plasma  lipid  levels  (9,  23,  24,  34,  35).  A  report 
confirming  the  proliferation  of  peroxisomes  and 
the induction of higher levels of total catalase with 
Su-13437  has been published recently (54).  In the 
present  work  we  show  that  proliferated  peroxi- 
somes  are  different  from  normal  peroxisomes: 
their  known  enzymes  are  strikingly  reduced  or 
suppressed,  while  the  peroxisomal  volume  per 
gram  liver  increases  several-fold.  For  the  first 
time,  a  specific determination  of the  turnover  of 
peroxisomal  oxidases  has  been  made,  together 
with that of catalase and soluble catalase after Su- 
13437,  yielding values compatible with simultane- 
ous  degradation.  We  also  present  evidence  that 
Abbreviations used in this paper." AIA, allyl isopropyl 
acetamide;  CPIB,  p-chlorophenoxy  isobutyrate;  DAB, 
3,Ydiaminobenzidine; DOC,  sodium deoxycholate; ML 
mitochondria  plus  light mitochondria subcellular frac- 
tion;  N,  nuclear  subcellular  fraction;  P,  microsomal 
subcellular fraction; S,  soluble subcellular fraction (all 
fractions  prepared  as  described  in  reference  18); 
Su- 13437,  2-methy|-2-(p-( 1,2,3,4-tetrahydro- t-naph- 
thyl)-phenoxy)-propionic acid; TCA trichloroacetic acid. 
the  content  of  proliferated  peroxisomes  is  ex- 
tracted,  presumably  through the  membrane, dur- 
ing  tissue  fractionation,  a  phenomenon  that  also 
affects  normal  peroxisomes  and  that  should  be 
taken  into  account  in  the evaluation of the isola- 
tion  procedures  and  in  the  determination  of  the 
subcellular  localization  of  peroxisomal  enzymes. 
Preliminary communications of some  of these re- 
sults have been made (39-41). 
MATERIALS  AND  METHODS 
Drug Administration and 
Preparative Procedures 
Male Sprague-Dawley rats, weighing 200  250 g, were 
used.  In  the  series  in  which  the  influence  of  sex  was 
studied  females  of  about  the  same  weight  were  used. 
Su-13437 was administered in a dose of 1 g,  and CPIB 
in a dose of 3 g per kg rat chow,  respectively. The ani- 
mals were  kept  in a  room  with controlled temperature 
and constant  12-h daily cycles of artificial illumination. 
The administration of the drug was started at 7-9 p.m. 
Rats  were  always  killed  between  9  and  10  a.m.  by 
decapitation,  without previous fasting. The  livers were 
homogenized after mincing, in 3 vol of 0.25 M sucrose at 
0~  with two strokes of a Potter-Elvehjem homogenizer 
Ethanol 0.1%  was  routinely added to  the sucrose solu- 
tions to protect catalase activity (42).  The homogenate 
was  further diluted  to  1:10  wt/vol,  filtered  through a 
double layer of surgical gauze, and aliquots of 10 ml were 
submitted to an integrated force of 380,000 g-min (17), in 
the outer row of an SM-24 Sorvall rotor by spinning for 
10  min  at  20,000  rpm.  Under  these  conditions,  the 
maximal  hydrostatic  pressure  to  which  the  pellet  was 
subjected  was  108  kg/cm 2.  The  supernate  from  this 
single-step,  simplified  fractionation  procedure  will  be 
referred to as the supernatant fraction, and the pellet as 
the  particle-bound  fraction.  This  procedure  gives  a 
complete sedimentation of peroxisomes and a  superna- 
tant fraction with some microsomes (17).  Regular mito- 
chondria plus light mitochondria (ML) particulate frac- 
tions and complete fractionations were made as described 
by de Duve et al. (18); the speed selected to sediment the 
ML pellet resulted in a maximal hydrostatic pressure of 
125 kg/cm ~ at the bottom of the centrifuge tube. 
Biochemical Determinations 
Protein was measured by the method of Lowry et al. 
(45).  DNA was determined with diphenylamine accord- 
ing  to  Burton  (13).  RNA  was  measured  with  the 
procedure of Fleck and Munro (21 ). Cytochrome oxidase 
and urate oxidase were assayed  as previously described 
(42).  Acid  phosphatase was  measured  according to de 
Duve  et  al.  (18).  For  catalase,  the  assay  used  by 
Baudhuin et al. (3) was employed. L-alpha-hydroxy acid 
oxidase and D-amino acid oxidase were determined with 
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dure described by  Neims (49),  forming and  measuring 
the pyruvate dinitrophenylhydrazone at  15~  Units are 
expressed as micromoles of pyruvate formed in 1 min per 
gram liver. 
Peroxisome Fragility 
Fragility was evaluated by morphological analysis, as 
described  below,  and  from  the  change  in  the  soluble 
fraction of catalase for peroxisomes, and acid phospha- 
tase for lysosomes. Lysosomes were included as a  con- 
trol. 0.25  M  sucrose, with 0.1% ethanol, was used as the 
homogenization  medium  unless  stated  otherwise.  Ho- 
mogenates  were  prepared  and  kept  at  0~  but  the 
activity  and distribution  of both marker  enzymes were 
not modified when proceeding at 20~  or 37~  Homo- 
genizations were  made  with  the same homogenizer, at 
1,200  rpm, for all fragility experiments; however, the use 
of 10-, 30-, or 55-ml homogenizers had no effect on the 
distribution of catalase or of acid phosphatase. The effect 
of prolonged homogenization was studied increasing the 
number of strokes from 2 to  19. The effect of increased 
viscosity  was  explored  with  1.8  M  sucrose  as  the 
homogenization medium. 
Morphological Observations 
Fixation for electron microscopy was made with 1.33% 
OsO4 buffered with 0.66  M  s-collidine, pH  7.6,  for 2 h 
(7). This fixative was adopted because of the high density 
it imparts to the peroxisomal matrix and nucleoid. Block 
staining  with  2%  aqueous  uranyl  acetate  was  done 
routinely  with  tissue  blocks  and  pellet  samples.  The 
sections, stained with lead citrate (62), were observed in a 
Siemens Elmiskop  IA electron microscope. Pellets were 
processed as follows: after gentle manual mixing in the 
sedimentation  tube  with  a  glass  rod,  a  sample  was 
suctioned with a  glass pipette and droplets of about 0.5 
mm  diameter  were  slowly  released  into  cold  fixative; 
after  30  min,  they  could  be  handled  as  tissue  blocks. 
Larger droplets should not be used since the penetration 
of  the  fixative  becomes  limiting.  For  histochemical 
analysis  of peroxidative  activity,  fixation  was  made  in 
Karnovsky's  fixative  (33),  and  the  DAB  procedure  of 
Graham  and  Karnovsky, as modified by  Novikoff and 
Goldfischer (50), was applied. Morphometric determina- 
tions of the maximal diameter of peroxisomal sections 
were made directly on the prints, one measurement per 
particle, in  such a  way that all recorded diameters were 
parallel to one of the edges. 
Protein Turnover Analysis 
We assume that the changes observed in the activity of 
peroxisomal enzymes were due to modifications of their 
rate constants of synthesis or degradation. Therefore, the 
changes have been treated in various ways, in agreement 
with the general theory of protein turnover in cells (55). 
The  following general equation  (8) was used  for the 
analysis of changes in enzyme levels: 
k,  k(2.~  a  Ete_,,,  E,= "~d  -  -  .  (1) 
Eo  and  E~  are,  respectively,  the  initial  and  the  final 
enzyme concentrations; k, the zero order rate constant of 
synthesis; ka the first order rate constant of degradation, 
and  t,  the time at  which Et  is measured. The equation 
reduces to  a  simple exponential if ks/ka becomes very 
small or zero. For a given experimental system in steady 
state,  ks/ka can  be  measured  since  it  is  equal  to  the 
enzyme concentration. The rate constant of degradation 
ka can thus easily be estimated following the evolution of 
enzyme concentration, on a  semilogarithmic plot, while 
the system changes to a  new steady state level (22).  In 
practice, we have assumed that steady state was reached 
after 6.5 days of drug administration. For catalase after 
AIA  (53)  and  the  change  in  o-amino  acid  oxidase 
activity, a  steady state level of 0 was assumed. 
Incorporation of [14C ]Leucine 
in vitro into Catalase 
and Liver Proteins 
Leucine  incorporation  in  liver  slices  was  used  to 
evaluate the effects of Su-13437 on the rate of synthesis 
of catalase and DOC-soluble liver proteins. One determi- 
nation,  with  a  single slice weighing about  80  rag,  was 
made  for each  rat;  to  minimize variations,  the dimen- 
sions of the slices were constant. Incubation was carried 
out  at  37~  for  l  h  in  1 ml  Krebs-Ringer phosphate 
medium (61) containing 1.25 t~Ci of OL-[~'C]leucine (25.6 
mCi/mmol),  in  an  atmosphere of 95%  oxygen and  5% 
carbon dioxide, in a shaking bath at 60 cycles per minute. 
After washing at 4~  with leucine-free medium, the slice 
was homogenized with 2 ml of 0.6% DOC in 0.05 M, pH 
8.0, Tris buffer. The supernate, after centrifugation for 
25 min at 45,000 rpm, contained all the catalase and the 
DOC-soluble liver proteins. 
Immunoprecipitation  of catalase  from  the  DOC  ex- 
tract was accomplished with rabbit anti-rat liver catalase 
antiserum. Pure rat liver catalase for immunization was 
prepared as previously described (43). The preparation of 
antiserum and the immunoprecipitation were carried out 
essentially as described by Higashi and Peters (26). The 
DOC  extract,  0.4  ml, was mixed with 0.2  ml  of crude 
antiserum and the immunoprecipitate resulting after l h 
at  37~  and  36  h  at 4~  was washed three times with 
0.15  M  NaC1 and dissolved in 0.5  N  NaOH.  A  0. l-ml 
sample was used for protein determination (45), and the 
rest for radioactivity measurement after reprecipitation 
with TCA in presence of I mg of bovine serum albumin. 
Protein precipitates for radioactivity counting were col- 
lected on glass fiber paper,  Whatman GF/C,  and after 
dehydration the radioactivity was determined by liquid 
scintillation in i0 ml of 0.4% BBOT (Packard Instrument 
Co., Downers Grove, Ill.) in toluene. 
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with two rats 25 h after subjecting them to a 70% partial 
hepatectomy.  A  66% increase in specific activity of the 
DOC-soluble liver protein was found, but no significant 
incorporation into immunoprecipitable catalase was de- 
tected.  In fact, hepatectomy induces an early and tran- 
sient drop in catalase activity (36) that is compatible with 
a block of its synthesis during the period studied. There 
are some uncertainties involved in immunoprecipitation 
of catalase from rat liver (52), since the catalase antigens 
present are heterogeneous (37, 38). Anyhow, the dissocia- 
tion observed in  regenerating liver constitutes an argu- 
ment for excluding contamination as the explanation for 
the label in the immunoprecipitate. 
Statistical Calculations 
Single  group  results  are  expressed  as  averages 
standard deviation. Two group comparisons have been 
made  applying Student's  t  test.  A  chi  square test was 
also  applied  to  the  frequency  of  peroxisomal  matrix 
extraction. The semilogarithmic plots for turnover analy- 
sis were derived from first class linear regression analy- 
sis,  with 95%  confidence  intervals calculated  from  the 
variance of the slope. 
Chemicals 
Substrates and reagents for chemical and histochemi- 
cal  enzyme determinations were  obtained  from  Sigma 
Chemical Co., St.  Louis, Mo., and chemicals of general 
use from  E.  Merck A. G.  Isotopes were  obtained from 
New  England Nuclear,  Boston, Mass.  Electron micros- 
copy  reagents  were  puchased  from  E.  F.  Fullam  Inc., 
Schenectady, N. Y. Su-13437 was supplied by Farbwerke 
Hoechst A.G.  and CPIB by Ayerst Laboratories, New 
York. 
R ESU LTS 
Body and Liver Growth 
At 0.1%  in the diet, Su-13437  markedly affects 
body  growth  (Fig.  1).  In contrast,  the  fraction of 
body  weight  corresponding  to  the  liver increases 
from 4.4 +  0.1 to 6.3 •  0.7. This change in relative 
mass  is due  to  an absolute  increase  in the  rate of 
liver growth,  maximal  between  0.5  and  3.5  days 
(Fig.  2),  and to a  decreased  rate of body growth. 
Liver Composition 
Different  biochemical  components  of the  liver 
were measured at 0, 0.5,  1.5,  2.5,  3.5, and 6.5 days 
after  treatment.  DNA  remains  constant  with  ex- 
perimental  values  not  significantly different  from 
the control value,  1.29  •  0.18 mg/g liver.  Protein 
concentration was  also  maintained within normal 
values:  159  •  14,  86  •  3,  and  71  •  5  for  total, 
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FIGURE  1  Body  growth  in  control (open  circles) and 
Su-13437-treated  rats  (filled  circles).  Two  animals per 
point in the control and four in the treated groups. In all 
figures, vertical bars over and below the average points 
represent one standard deviation. 
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Liver growth  in  control  (open  circles) and 
Su-13437-treated  rats  (filled  circles).  The  curves  were 
calculated  from  the body growth data  and the average 
body weight fraction corresponding to the liver at various 
intervals.  Treatment  increases  the  fraction  of  body 
weight corresponding to the liver from 4.4 ~  0.1 to 6.3 :i_ 
0.7. 
particle-bound, and supernatant activities in milli- 
grams per gram  liver. The concentration of RNA 
changes  rapidly,  reaching a  peak  value,  20%  over 
the control, after 0.5 day (Fig. 3). Marker enzymes 
for some cell organelles were followed: acid phos- 
phatase values for total, particle-bound, and super- 
nate  activities were not different from the control 
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U/g  liver,  respectively;  however,  as  shown  later,  loo 
there  was  some  effect  on  the  distribution  of the  A 
enzyme. Cytochrome oxidase rose slowly from the  ~  ao 
normal  value,  31.9  •  5.7  U/g  liver, at  a  statisti-  ->, 
cally  significant  average  rate  of  1.1  U  per  day,  ~  so 
during  the 6.5 days of observation. 
The  most  striking  biochemical  effects  after 
40 
Su-13437  administration  were detected  on  perox- 
isomal enzymes. The total  activity for each of the  ,~ 
20 
oxidases  gradually  decreases  on  a  gram  liver 
weight basis,  while that  of catalase  increases. The 
increase  in catalase activity results from the alge-  o 
braic sum of a  severalfold increase in the superna- 
tant  fraction  of the enzyme, plus a  marked  reduc- 
tion  in the particle-bound  fraction (Fig. 4).  Urate 
oxidase decreases  by  approximately 40%  (Fig.  5). 
L-Alpha-hydroxy  acid  oxidase  decreases  by  ap- 
proximately 70%, and  D-amino acid oxidase prac- 
tically  disappears  (Fig.  6  and  Fig.  7);  for  both 
enzymes  the  change  affects  the  supernate  and 
particle-bound  activities.  _  ~ - 
ee 
Comparative Effects of Su-13437 and  ~- 
CPIB and Influence of Sex 
A  comparative  study  of the effect of Su-13437 
and  of the  chemically  and  pharmacologically  re-  - 
lated  drug  CPIB was  carried  out  on  rats  of both  1 
sexes.  Su-13437  was  administered  at  the  regular 
g:l 
dose of 1 g per kg chow and CPIB at 3 g per kg, a  t, 
go- 
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administration.  Control rats have  10.4 -4- 0.6 mg RNA 
per gram liver. The points under treatment correspond to 
4 rats,  10 rats for the control. Levels at 0.5 and  1.5 days 
differ significantly from control values; P  <  0.001. 
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FIGURE 4  Catalase  activity  in  liver during  Su-13437 
administration.  Total  (open  circles),  particle-bound 
(filled  circles)  and  soluble  activities  (triangles).  Each 
point is the average of four rats. 
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FIGURE  5  Urate  oxidase  activity  in  liver  during 
Su-13437  administration.  Each  point  is the  average of 
four rats. 
dose commonly used  in experimental studies with 
this  drug.  The  results,  shown  in Table  1,  demon- 
strate  that  both  drugs,  administered  during  6.5 
days, have similar qualitative effects on the activity 
and  distribution  of  peroxisomal  enzymes.  The 
changes  induced  are  larger  in  male  rats.  In  this 
particular  experimental  series,  only Su-13437  in- 
duced an increase in catalase activity of male liver, 
although  both  drugs  increased  the  supernatant 
fraction. This reduced response is not due to errors 
in  the  administration  of the  drug,  since  the  oxi- 
dases show the usual decrease in concentration.  In 
fact, in our laboratory, the response of this enzyme 
to  Su-13437  has  an  apparently  seasonal  fluctua- 
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FIGURE 6  L-Alpha-hydroxy  acid  oxidase  activity  in 
liver during  Su-13437  administration.  Total (open  cir- 
cles),  particle-bound  (filled  circles),  and  soluble  activi- 
ties (triangles).  10  rats  for the control level,  and  4  for 
each point under treatment. 
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FIGURE 7  D-Amino acid oxidase activity in liver furing 
Su-13437  administration.  Total (open  circles),  particle- 
bound (filled circles), and soluble activities (triangles).  10 
rats  for  the  control  level, and  4  for each  point  under 
treatment. 
tion.  Higher  induced  levels  are  found  in  winter. 
The  results  shown  in  Table  1  were  obtained  in 
summer  while those  from  Fig. 4,  where a  marked 
effect  on  catalase  is  illustrated,  were  obtained  in 
winter.  In another observation made in winter, the 
effects of both  drugs  were compared  in groups  of 
six  male  rats.  The  following  values  were  found: 
control,  52.1  •  3.3  U;  Su-13437-treated,  96.3  • 
4.8  U; CPIB-treated,  66.5  •  7.0  U. The  fluctua- 
tion could be due to changes in the diet composi- 
tion,  but  we have  no evidence to prove it.  At any 
rate, to account  for it, control values were always 
obtained  simultaneously  with  the  experimental 
groups. 
The  activity of D-amino  acid oxidase  is almost 
completely suppressed  in  both  males and  females 
by  Su-13437,  while CPIB exerts  only a  moderate 
effect. The activities of urate oxidase and  L-alpha- 
hydroxy  acid  oxidase  are  also  depressed  by 
Su- 13437  in males and females, while CPI B, which 
in  males  is  less  active,  exerts  no  influence  in 
females. 
Whenever  the  drugs  have  some  effect  on  the 
concentration  of peroxisomal  enzymes  there  is  a 
shift  in  their distribution,  a  larger fraction  of the 
catalase  and  the soluble oxidases appearing  in the 
supernate.  Urate oxidase always remains insoluble 
or particle bound. 
We may conclude that both drugs affect the level 
and  distribution  of  peroxisomal  enzymes. 
Su-13437  is  more  active than  CPIB;  both  act  on 
male rats, while only Su-13437 shows a clear effect 
on the peroxisomal enzymes of the females. 
Liver  Structure 
A  rough  estimation  of the  frequency,  size, and 
distribution of peroxisomes can be obtained from a 
TABLE I 
EfJect of Su-13437 and CPIB on the Activity and Distribution of Liver Peroxisomal Enzymes. Male and 
Female Rats Treated for 6.5 Days 
Catalase  DAAO  LaHAO  Urate oxidase 
U/g  % in S  U/g  % in S  U/g  % in S  U/g 
Males 
Control (4)*  61.1  .4- 4.5~  29.1  .4- 3.2  0.535 .4- 0.208  12.8  .4- 2.5  0.503 .4- 0.093  20.8 .4- 3.1  3.22 •  0.45 
Su-13437 (4)  74.5 .4- 4.5  63.3 .4- 7.0  0.032 .4- 0.021  30.9 -4- 24.0  0.164 .4- 0.023  42.2 .4- 5.0  1.48 .4- 0.19 
CPIB (4)  59.0 .4- 5.1  50.2 .4- 3.3  0.148 •  0.026  32.7 •  4.2  0.248 •  0.021  37.0 .4- 2.6  1.92 •  0.15 
Females 
Control (4)  30.1  .4- 2.0  25.8 .4- 8.0  0.441  .4- 0.124  8.8 .4- 4.4  0.255 .4- 0.044  17.4 -4- 4.7  3.99 •  0.17 
Su-13437 (4)  53.1  •  46.7.4-4.9  0,057 •  0.010  20.2.4-6.6  0.173 •  0.017  25.1  :i: 3.2  2.90 •  0.15 
CPIB (4)  40.8.4-6.0  16.4 •  3.5  0.302 •  0.130  6.1  •  1.7  0.284 •  0.013  12.8  •  2,5  3.61  •  0.51 
* Number of individual  determinations. 
Average value ~:  SD. 
DAAO  ffi D-amino acid oxidase. 
LaHAO  =  L-alpha-hydroxy acid oxidase. 
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chemical  detection  of  peroxidative  activity  with 
DAB.  As shown  in  Fig.  8,  in normal liver cells, 
peroxisomes appear as isolated particles or small 
linear clusters distributed at random in the cyto- 
plasm.  In hepatocytes from treated  rats (Fig. 9), 
they  are more numerous, bigger, and distributed 
at  random in the entire cytoplasmic area; in this 
case,  clusters are difficult to detect because of the 
high frequency of peroxisomes. 
The relative frequency and structural character- 
istics  of  normal peroxisomes  under the  electron 
microscope are illustrated in Fig.  10. The organ- 
elles show a finely granular matrix, with the same 
electron density for  all particles,  that  often con- 
tains  a  heavily  stained  nucleoid.  The  average 
diameter of sections through normal peroxisomes 
was  found  to  be  0.58  •  0.15  am  (Table  II). 
Normal peroxisomes give a  positive DAB perox- 
idatic reaction, with approximately the same con- 
centration or density of the reaction product in all 
particles  (Fig.  11). Starting  at  1.5  days  after 
treatment, Su-13437 induces changes in the  liver 
structure:  as  illustrated  in  Fig.  12,  continuities 
between  the  peroxisomal  membrane  and  mem- 
brane fragments that  look  like smooth endoplas- 
mic  reticulum  profiles  are  more  frequent.  The 
nucleoid,  which  will  later  transitorily disappear 
from  almost  all  proliferated  peroxisomes,  fre- 
quently looks partially disaggregated, and is occa- 
sionally seen free in the cytoplasm. Also, after 1.5 
days,  and not at other time intervals, practically 
all  lipid  droplets  are  almost  completely  sur- 
rounded  by  smooth  endoplasmic reticulum pro- 
files. 
After  3.5  days  of treatment, the  morphologic 
characteristics  of  proliferated  peroxisomes  are 
clearly different from  those  of normal particles. 
The  peroxisomes  look  the  same  after  6.5  days, 
except  that  the  nucleoid, practically absent after 
3.5  days,  is  again  occasionally  seen  (Fig.  13). 
Peroxisomes are bigger, some having a diameter of 
1 ~tm  or  more,  and  present  a  variable electron 
density  of the  matrix  in different  particles.  The 
average diameter of sections through proliferated 
particles is 0.73  +  0.25 ~m. Those with very low 
electron  density  were  identified  as  peroxisomes 
FIGURE 8 and 9  Thick  sections through Epon-embed- 
ded liver tissue after incubation with 3,Y-diaminobenzi- 
dine (DAB), to detect peroxidatic activity. Peroxisomes 
and  red  blood cells show a  positive reaction.  Fig. 8 
corresponds to a normal rat and Fig. 9 to a rat treated 
with Su-13437 for 6.5 days. The increase in number and 
size of peroxisomes is clearly detectable. ￿  1,650. 
LEIGHTON, COLOMA, AND KOENIG  Peroxisome Proliferation  lg7 FIGURE  10  Normal rat liver.  The section illustrates the morphological characteristics of peroxisomes in 
tissue  fixed  with  s-collidine-buffered  osmium  tetroxide.  Peroxisomes (arrows) show a  heavily  stained 
nucleoid and a finely granular matrix. They are smaller and less numerous than mitochondria. ￿  12,000. 
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Diameter of Peroxisomal Sections in Liver and in 
Tissue Fractions* 
Sample  Controls  Su- 13437  p 
Liver tissue 
Pellet from single 
step fractiona- 
tion 
Pellet from ML 
fraction 
~rn  ~m 
0.58 •  0.155  0.73 •  0.25  <0.005 
0.59•  0.69•  <0.010 
0.56•  0.69+0.18  <0.001 
* An average of 68 peroxisomal sections, randomly selected, was 
used for each group. 
Results are expressed as average diameter, in um•  SD. P  for 
the differences was calculated applying Student's t test. 
after a positive DAB reaction had been found, as 
shown in Fig.  14, at all time intervals. In contrast 
to normal particles, proliferated peroxisomes often 
show a variable concentration or density of DAB 
peroxidative  product;  the  larger  sections,  which 
usually  correspond  to  the  low  electron  density 
particles, show less reaction product than the small 
forms. There are also areas where all proliferated 
peroxisomes have a very homogeneous histochemi- 
cal reaction, as shown in Fig. 15. This micrograph 
also shows  proliferation of the smooth endoplas- 
mic reticulum, a phenomenon also apparent in Fig. 
13 where the profiles appear fragmented, presum- 
ably because  of the  different  fixation employed. 
Since our attention was focused on the morpholog- 
ical changes that are detected while normal peroxi- 
somes are being replaced by proliferated ones, the 
results of chronic administration of Su- 13437 were 
checked  at  only one time  interval, 45  days.  The 
main  findings  after  chronic  administration  are 
shown in Fig. 16: the nucleoid is again present, and 
peroxisomes  have  either  a  normal  matrix  or  a 
flocculent, low electron density content. Mitochon- 
dria,  after  chronic  treatment,  show  abnormal 
aggregation of cristae. 
Peroxisome-containing  autophagosomes  were 
seen occasionally in both control and treated rats 
(Figs.  17,  18). Their  frequency was  low  and  no 
correlation could be established with the adminis- 
tration of Su- 13437. 
Physical Properties of Proliferated 
Peroxisomes.  Biochemical and 
Morphological  Observations 
The subcellular distribution of peroxisomal en- 
zymes  during  Su-13437  administration suggests 
that  the  organelle is  no longer able to  retain its 
contents.  Fig.  19  shows  the  average  change  in 
distribution  of  peroxisomal  enzymes,  excepting 
urate oxidase which  is not soluble. The increase in 
the supernatant fraction of catalase is remarkable 
for its magnitude and also for the small scattering 
of individual values,  as  reflected  in the  standard 
deviations.  L-alpha-hydroxy acid  oxidase  and  D- 
amino acid oxidase also increase in the supernate, 
but less  than catalase. The increase for D-amino 
acid oxidase is not statistically significant: a large 
scattering of values  resulted  from  calculation of 
the ratio of residual activities. The shift in enzyme 
distribution does not affect the bulk of cell organ- 
elles since the protein distribution is not changed; 
in fact, for acid phosphatase, precisely the opposite 
effect  is found (Fig. 20). 
In order to explore an eventual increase in the 
fragility of proliferated peroxisomes, leading to a 
larger  fraction  of  broken  or  disrupted  particles 
after  homogenization, the  procedure  was carried 
out under more severe conditions: prolonged expo- 
sure to shearing forces by homogenization with 19 
instead  of  2  strokes;  and  homogenization  in  a 
viscous medium to increase shearing forces:  1.8 M 
sucrose, equivalent to a 20-fold increase in viscos- 
ity.  Adequate  controls  were  used  for  the  latter 
condition,  since  the  final  sucrose  concentration 
after  homogenization and  dilution was  0.43  M. 
Rats treated for 3.5 days were used, since that time 
appears to be the moment of maximal fragility and 
at that time the oxidases have not yet reached their 
minimum level. 
The  results  shown  in  Table  ill  indicate  that 
catalase was slightly released by prolonged homog- 
enization in control but not in treated rats. How- 
ever,  in  1.8  M  sucrose,  almost two-thirds of the 
catalase  is present in the  supernate from control 
rats; in treated rats, there was a  further increase, 
but  not  a  statistically  significant  one,  of  the 
already  large  soluble fraction.  Acid phosphatase 
distribution was not affected by prolonged homog- 
enization; but, in the viscous medium, there was a 
minor release, slightly higher for the controls. The 
supernatant fraction of acid phosphatase, in con- 
trol  and  severe  homogenization  conditions,  is 
always slightly lower for treated  rats. This corre- 
lates with the temporal course of acid phosphatase 
distribution that shows  a decrease in the superna- 
tant  fraction  (Fig.  20).  Therefore,  a  minor but 
significant  apparent  stabilization  of  lysosomes 
follows drug administration, precisely the opposite 
LEIGHTON,  COLOMA,  AND  KOENIG  Peroxisome Proliferation  289 FIGURE  11  DAB peroxidation  in  control liver. The peroxisomes are selectively stained by the reaction 
product.  ￿  15,000. 
2~  THE  JOURNAL OF  CELL  BIOLOGY ￿9  VOLUME 67,  1975 FIGURE  12  Hepatocyte  structure  after  1.5  days  of  Su-13437  administration.  Continuities  between 
peroxisomes and smooth membrane profiles are detected (arrows). Partial disaggregation of the nucleoid is 
seen in two particles (D),  illustrating the temporal disappearance of the structure that follows treatment. 
Smooth endoplasmic reticulum  profiles (M) were frequently seen around peroxisomes and lipid droplets at 
this stage. The background (G) corresponds to a glycogen area which is not stained with the fixative and 
stains employed, x  18,000. 
291 FIGURE  13  Liver structure after 6.5 days of Su-13437.  Peroxisomes are pleomorphic,  more numerous, 
and larger, even larger than mitochondria. The electron density of the matrix is not the same in different 
particles  (arrows).  Nucleoids  are  practically  absent.  There  is  a  moderate  proliferation  of the  smooth 
endoplasmic reticulum, which also appears fragmented.  ￿  12,000. 
292  ThE  JOURNAL OF  CELL  BIOLOGY ￿9  VOLUME  67,  1975 FIGURE  14  DAB  peroxidation  in  rat  liver  after  6.5  days  of Su-13437.  In  this  section, the  numerous 
proliferated  peroxisomes show circular  profiles that  contrast  with  those illustrated  in  Fig  15.  The  size 
distribution  of peroxisomes is  much  wider  than  that  observed in  control liver;  several particles have  a 
diameter larger than  1 urn, but there are also many small particles. The intensity of the DAB peroxidation 
product is higher in the smaller particles, a  peculiar property of proliferated peroxisomes, x  13,500. 
LEIGHTON, COLOMA, AND  KOENIG  Peroxisome Proliferation  293 FIGURE  15  DAB  peroxidation in  rat  liver after  6.5  days of Su-13437. In  this section, proliferated 
peroxisomes show a uniform deposit of reaction product and an irregular profile that is often present after 
treatment. The smooth endoplasmic reticulum appears proliferated, but not fragmented into vesicles  as in 
Fig. 13, presumably because of the aldehyde fixation used for histochemistry. ￿  20,000. 
effect  postulated for peroxisomes. The distribution 
of protein was  not  modified by drug administra- 
tion  under  any  of  the  tests,  but  the  amount 
sedimenting in 0.43  M sucrose is less than in 0.25 
M,  a  result to  be expected  since, in spite of the 
increase in viscosity, density, and osmolarity of the 
medium, the same integrated force was applied for 
sedimentation. We may conclude that, under con- 
ditions  leading  to  a  partial  release  of  particle- 
bound  catalase,  the  peroxisomes  present  in  the 
particulate fraction  of treated  rats did  not  show 
more fragility than those from control rats. 
The absence of a detectable increase in peroxiso- 
real  fragility does  not  rule  it  out.  The  particles 
resisting the  fractionation could  be  the  stronger 
ones,  while  labile  particles  would  be  disrupted 
already  under normal homogenization and  frac- 
tionation conditions. Then the effect  of Su-13437 
would be to increase the fraction of labile particles. 
Many proliferated peroxisomes are in fact bigger 
and might contain a major portion of the enzymes; 
further,  they  should be  mechanically more labile 
than  small  forms.  To  determine if large  peroxi- 
somes are selectively broken during fractionation, 
the diameter of sections through the organelle in 
liver of normal and treated rats was compared with 
that  of  sections  through  peroxisomes  present  in 
particulate fractions, after the single-step fraction- 
ation and in the  ML fraction of the multiple step 
procedure. As shown in Table II, the diameter of 
peroxisomal sections was the same, in control and 
treated  rats,  for particles fixed  in situ  and in the 
pellets.  Su-13437 treatment results in a 22% aver- 
age  increase in diameter in the tissue and in the 
pellets from both fractionation procedures. So, if 
there  was breakage of particles during fractiona- 
tion, it did not affect selectively large peroxisomes. 
The  fraction  of  catalase  bound  to  particles 
depends upon the fractionation procedure used.  In 
Su-13437-treated rats, the  pellet from the simpli- 
fied  fractionation contained 28.5  :~  2.3% of the 
enzyme,  and  the  N  plus  ML  fractions  of  the 
complete fractionation only  l l.8  +  3.0%.  The N 
plus the  ML  fractions from the control rats also 
had  a  significant decrease  of  particle-bound en- 
zyme (Fig. 21), when compared with the distribu- 
tion after the simplified fractionation. 
This increased solubilization of catalase in con- 
trol  and treated  ra~s, after fractionation with  the 
regular,  multiple-step procedure,  correlates  with 
294  THE  JOURNAL OF  CELL  BIOLOGY  .  VOLUME 67,  1975 the  frequency  at  which  particles  showed  matrix 
extraction  with  formation  of ghosts  (Table  IV). 
This phenomenon, illustrated in the  micrographs 
of sections through the pellets from both fractiona- 
tion  procedures  (Figs.  22-25),  affects  preferen- 
tially the larger peroxisomes with the formation of 
ghosts  or  empty  particles.  The  residual  matrix 
adheres to the inner side of the membrane, forming 
loose clumps. Most extracted  particles are in the 
form  of ghosts.  Partially extracted  peroxisomes, 
which allowed us to identify the big empty vacuoles 
as  damaged  peroxisomes,  are  not  frequent  and 
were seen preferentially in the pellet from control 
rats (Figs. 22 and 24). 
As a general conclusion, we can say that changes 
in shearing forces induced during homogenization 
did not allow the detection of different mechanical 
properties  in proliferated  peroxisomes,  but these 
particles were sensitive to the overall fractionation 
procedure. No morphological evidence of particle 
breakage during fractionation could be obtained, 
but the degree of matrix extraction, in normal and 
treated  rats,  correlates  with  the  solubilization of 
catalase. These  results suggest that the extracted 
peroxisomes are responsible for a large fraction of 
the catalase not bound to particles, in control and 
Su- 13437-treated rats. 
[  ~4C]Leucine  Incorporation 
The  radioactivity  incorporated  in  liver  slices, 
expressed as counts per gram liver in DOC-soluble 
and immunoprecipitable protein, is shown in Fig. 
FIGURE 16  Liver  structure after 45 days of Su-13437 administration. Peroxisomes are proliferated and 
have either a normal or a flocculent, low electron density matrix. Nucleoids are present in both types of 
peroxisomes. A few mitocbondria show abnormal aggregation of cristae. ￿  12,000. 
LEIGHTON, COLOMA, AND KOENIG  Peroxisome  Proliferation  295 FIGURE  17  Peroxisome-containing  autophagosome  in  control  liver.  This  micrograph  illustrates  a 
constant but infrequent finding. The matrix shows signs of disaggregation that  are  never seen in  normal 
peroxisomes  free  in  the  cytoplasm.  The  background  of  the  micrograph  corresponds  to  an  unstained 
glycogen area.  ￿  24,000. 
FIGURE  18  Peroxisome-containing  autophagosomes  in  the  liver  of  a  rat  treated  for  3.5  days  with 
Su-13437 (arrows).  The peroxisome inside the larger phagosome has already  released part  of its content. 
The section also shows several proliferated  peroxisomes free in the cytoplasm,  x  24,000. 
296  THE  JOURNAL OF  CELL  BIOLOGY - VOLUME 67,  1975 26.  Maximum  incorporation was attained after  1.5 
days of treatment, a  moment when the rate of liver 
growth  seems  to  be  maximum  and  yet  not  much 
extra tissue mass has accumulated  (Fig.  2).  Incor- 
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FIGURE  19  Soluble  activtty  of  peroxisomal  enzymes 
during  Su-13437  administration.  Catalase,  L-alpha- 
hydroxy acid oxidase, o-amino acid oxidase, and  urate 
oxidase activities were followed. Urate oxidase was not 
drawn  since  it  remained  always  completely  bound  to 
particles. Each point corresponds to the average percent 
fraction of soluble vs. soluble plus particle-bound activi- 
ties, from four to six rats. To simplify the graph, only one 
standard  deviation  bar  has  been  indicated  for  some 
points,  upwards  for  catalase  and  downwards  for  the 
oxidases;  for  the  last  point  of  DAAO,  the  bars  are 
slightly  displaced  and  interrupted.  Data  derived  from 
single-step fractionations,  10 min at  20,000  rpm  in the 
Sorvall SM-24 rotor. 
poration into antigenic material is doubled, while a 
lower  increment  is  detected  in  the  DOC-soluble 
protein. 
The  effect  on  antigenic  catalase  is  partially 
explained by the increase in immunoprecipitate per 
gram  of  liver  that  follows  Su-13437  administra- 
tion:  control  rats  had  21.5  •  1.5  mg of immuno- 
precipitate per gram  of liver, and  19.3  :e  2.2,  25.4 
•  0.8, 25.5  •  2.1, and 28. I  •  1.7 after 0.5,  1.5, 3.5, 
and  6.5  days.  These  values  correspond  to  an 
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Distribution  of acid phosphatase and pro- 
tein during Su-13437  administration.  Each point corre- 
sponds  to  the  average  percent  fraction  of soluble  vs. 
soluble plus particle-bound activities from four rats. The 
data  derive  from  single-step  fractionations.  The  slight 
decrease in percent soluble activity of acid phosphatase is 
significant: 0.001  <  P  <  0.01  for the significance of r 
against zero. 
TABLE !11 
Release of Particle-Bound  Enzymes under  Different Homogenization  Conditions.  Liver from Male Rats  Treated 
for 3.5 Days  with Su-13437 
Sedimentation in 0.25 M sucrose 
Homogenization conditions ........ " 2 strokes in 0.25  19 strokes in 0.25 
M sucrose  M sucrose 
Sedimentation in 0.43 M sucrose 
2 strokes in 0.25  2 strokes in 1.8 
M sucrose  M sucrose 
n=8  n=4  p*  n=4  n=8 
Catalase (control)  69.5 •  5.41:  61.3 -~ 3.9  <0.025  61.0 •  0.5  36.2 •  4.2 
Catalase (Su-13437)  30.6 •  4.1  30.8 •  2.9  > 0.05  28.3 •  5.0  22.9 •  4.3 
Acid phosphatase (control)  84.7 •  2.1  83.2 •  0.9  > 0.05  83. l •  0.9  74.5 •  1,8 
Acid phosphatasc (Su-13437)  87.5  •  1.2  85.0 ~=  1.7  <0.02  86.7 •  2.0  79.3 •  1.6 
Protein (Control)  54.7 •  1.8  54.5 -~ 0.8  >0.05  51.0 •  3.3  49.2 ~- 2.7 
Protein (Su-13437)  54.5  •  2.7  55.8 •  5.8  >0.05  51.7 •  1.6  50.9 •  1.7 
P 
<0.001 
> 0.05 
<0.001 
<0,001 
> 0.05 
> 0.05 
* P  for the differences calculated applying to Student's t test. 
Average percent +  SD of total activity bound to particles, 
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FIGURE 21  Effect of Su-13437 on the subcellular  distri- 
bution of catalase, acid phosphatase, cytochrome oxidase 
and protein. Tissue fractionation was carried out accord- 
ing to de Duve et al. (18) by sequential centriugations and 
washings  at several increasing values of integrated cen- 
trifugal force. The abscissa  represents cumulative percent 
protein. The ordinates,  percent of enzyme activity over 
percent of protein, i.e.  relative specific activity, for each 
fraction. The results  shown correspond to the average of 
three  fractionations on control rats and  four fractiona- 
tions  on  rats  treated  with  Su-13437  for 6.5  days.  The 
values for the per cent protein distribution in N, ML, P, 
and S were 11.4 •  2.2, 25.8 •  2.6, 26.8 -4- 2.2, and 35.9 + 
2.4 for control rats, and  11.2 +  1.1, 30.8  •  2.4, 24.3 
1.2, and 33.7 +  2.3, for treated rats.  Therefore, a slight 
increase  in  the  protein  content  of the  ML  fraction  is 
detected  (0.025  <  P  <  0.050).  Acid phosphatase  and 
cytochrome  oxidase  distributions  are  not  affected  by 
treatment.  Catalase,  at the new induced  levels, shows  a 
marked change in distribution: percent values were 3.7 • 
1.9, 48.9  +  12.8, 12.5 •  1.8, and 34.9 •  15.2 for control 
rats, and  1.7 4- 0.5,  10.1 •  2.7, 7.6 •  1.4, and 80.7 •  3.5 
for treated rats,  in the N, ML, P, and S fractions. The 
activities of the enzymes and  the amount of protein per 
gram liver were no different from the values found for the 
other experimental series  in this work. 
average 310.2  •  52.5 ~g of precipitated protein per 
unit  catalase  activity at  all time  intervals.  DOC- 
soluble protein  levels remained  unchanged  during 
the peak of leucine incorporation:  184  •  18 mg in 
control  rats,  and  165  •  8,  181  •  5,  197  •  7, and 
207  •  7  mg per gram  of liver, after 0.5,  1.5,  3.5, 
and  6.5  days  of  treatment.  The  slight  increase 
detected  by  the  end  of  the  observation  period 
correlates  with  the  data  for  total  protein.  That 
DOC-soluble  protein  levels  are  somewhat  higher 
than  those found for the homogenate  is attributed 
to less material  being  retained during  filtration. 
The  counts  per gram  of liver incorporated  into 
antigenic  material  are,  for control  rats,  0.22%  of 
the counts  found  in  DOC-soluble proteins.  When 
the  results  are  expressed  as  specific  activities, 
control  rats  had  1,375  •  189  cpm per mg DOC- 
soluble protein and 26.2  •  2.8 cpm per mg protein 
of the immunoprecipitate. 
These  results  show  that  immunoprecipitable 
catalase  increases by  18-30%  after Su-13437,  and 
that  the  apparent  change  in  the  rate  of synthesis 
that  follows drug  administration  is higher for the 
antigenic  material  than  for  the  average  DOC- 
soluble liver protein. 
Turnover of Peroxisomal Enzymes 
The turnover rates of total and  soluble catalase 
and of D-amino acid oxidase, L-alpha-hydroxy acid 
oxidase, and  urate oxidase were measured accord- 
ing  to  the  procedures  detailed  in  Materials  and 
Methods. The halflives estimated from the changes 
in  activity  after  Su-13437,  or  after  AIA  for 
catalase in control and Su-13437 treated rats, have 
been summarized in Table V. The half-life for total 
catalase  is  not  affected  by  the  administration  of 
Su-13437.  The  half-life  of  induced  supernatant 
catalase,  estimated  from  the  kinetics  of enzyme 
accumulation  during  induction,  does  not  differ 
from  the  determinations  with  total  catalase  (Fig. 
27).  The  half-lives  for  the  oxidases,  calculated 
from  the  kinetics  of  the  change  in  activity  to  a 
lower level that  for D-amino acid oxidase is prac- 
tically  zero,  cannot  be  differentiated  statistically 
when  compared  to  one  another,  or  with  any  of 
the  catalase estimations  (Fig.  28).  The  main  con- 
clusion  derived  from  these  results  is  that,  in 
treated  rats,  the  soluble  catalase  and  all  the 
peroxisomal enzymes studied  have the same half- 
life with an approximate value of 1.3 days, which is 
no different from the half-life of catalase in normal 
rats.  In  the  case  of  D-amino  acid  oxidase,  its 
behavior after administration of Su- 13437  suggests 
that  its synthesis is blocked  by the drug. 
DISCUSSION 
Extending  our  previous  observations  (39),  we 
have shown that Su-13437 exerts a marked trophic 
effect on rat liver peroxisomes. It is more active on 
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Peroxisome Matrix Extraction after Liver Fractionation 
Controls  Su-13437  p 
%  % 
Pellet  from single step fraction-  53.7 4-  11.0"  96.7 4- 3.9  <0.001 
ation  (53.6)I  (96.1) 
Pellet from ML fraction  67.8 4-  10.8  100.0 4- 0.0  <0.001 
(67.1)  (100.0) 
P  <  0.02  P  <  0.02 
* Average percentage  +  SD. Separate determinations, on an average of 14 micrographs, were made for each group. 
Each micrograph was considered as a different sample. Calculation of P for the effect of treatment, right side column, 
and for the effect of the fractionation procedure,  lower line, was made applying Student's t test. 
Figures in parenthesis are the effective  frequencies,  in percent of matrix-extracted sections,  derived  from all the 
sections examined. A chi square test applied to the effective frequencies, for the increase in matrix extraction observed 
in the pellet  ML as compared to the pellet from the single-step  method, gave a P  <  0.025 for control rats. 
a  molar basis than  CPIB,  another lipid-lowering 
substance that  qualitatively has similar effects on 
peroxisomes (25, 54, 56, 58). Yet, only Su-13437 is 
active on peroxisomes of female rats, and the effect 
we describe on D-amino acid oxidase, equivalent to 
a  complete block of its synthesis, is not shared by 
CPIB.  Differences  in  the  metabolism  of  these 
drugs have been found (10) and could explain their 
properties.  Su-13437  also  shows  a  nonspecific 
effect on liver mass, apparently due to hyperplastic 
growth; only minor changes in the concentration of 
various cell components were detected, in contrast 
with observations on mice (5), where the effect was 
attributed to both hyperplasia and hypertrophy. 
Peroxisome Proliferation 
The volume fraction of liver cells corresponding 
to  peroxisomes  increases several-fold  after  treat- 
ment  with  Su-13437.  This  effect  has  not  been 
quantitated by morphometry but is apparent in our 
morphologic  illustrations. Some  sections through 
proliferated  peroxisomes  are  very  large,  with  a 
diameter of 1.0 um or more, which is not found in 
the controls. The 22% average increase in diameter 
of  peroxisome  sections  does  not  allow  a  direct 
estimate  of  the  increase  in  the  volume  of  the 
organelle because of morphometric considerations 
(4). 
The matrix changes in proliferated peroxisomes 
are  remarkable  and point again to  the change  in 
the  properties  of  the  organelle.  The  forms  with 
decreased  electron  density  of  the  matrix  might 
correspond  to  particles  being destroyed  by  atro- 
phy, one of the mechanisms of peroxisome destruc- 
tion described by Locke and McMahon in the fat 
body  (44).  But  low  density  forms  also  recall the 
relation  between  condensing vacuoles and zymo- 
gen granules in the  pancreas (32),  a  resemblance 
that  could be further explored with autoradiogra- 
phy. In rat liver, the normal mechanism of peroxi- 
some degradation is not known, but autophagy is a 
likely process,  judging from  the  observations on 
insects (44), and after various experimental condi- 
tions  (31).  Phagosomes  with  partially  degraded 
peroxisomes, though not frequent, were a constant 
finding in normal and treated  rats. 
The  nucleoid  of  peroxisomes  appears  frag- 
mented initially. As the treatment continues, prac- 
tically  all  peroxisomes  lack  a  nucleoid,  but  the 
structure  is  again detectable,  with  a  normal  fre- 
quency,  after  several  weeks.  Occasionally,  intact 
nucleoids were  observed  in the  cytoplasm.  Urate 
oxidase, the only protein identified in the nucleoid, 
does not lose its activity after in vitro solubilization 
(43) and, further, nucleoids can be reassembled in 
vitro by reprecipitation (F.  Leighton, unpublished 
observations).  Apparently, the  assembly of urate 
oxidase as the nucleoid of peroxisomes seems to be 
affected  by  Su-13437,  since  fragmentation,  as 
shown  in  Fig.  14,  was  frequently  seen  at  early 
periods. But soluble fractions, at all time intervals, 
were  systematically  negative  for  urate  oxidase 
activity. 
Catalase in the Supernate 
The increase in the soluble fraction of catalase is 
such  that  the  units  of  soluble catalse,  per  gram 
liver, increase four- to fivefold after treatment. At 
LEIGHTON, COLOMA, AND  KOENIG  Peroxisome Proliferation  299 FIGURE 22  Particulate  fraction  from control liver, prepared by the single-step simplified fractionation 
procedure.  Microsomal vesicles (M) are very abundant. There are normal peroxisomes (N, arrows), but 
most  of them  are  affected by  matrix  extraction  with  the  formation  of ghosts (arrows).  Partial  matrix 
extraction is occasionally seen (E arrow). 53.7  +  11.0% of the peroxisomal profiles were found extracted in 
micrographs from control rats after this fractionation procedure. The diameter of peroxisomal sections is 
larger for the extracted forms.  An average value  of 0.59  :~  0.15  ~.m,  no different from the diameter of 
sections in  control liver,  was  found  in  micrographs of particulate  fractions prepared  by the  single-step 
method.  ￿  12,000. 
3O0 FIGURE 23  Particulate fraction from the liver of a rat treated for 6.5 days with Su-13437, prepared by the 
single-step simplified fractionation  procedure.  There  is  one  normal  peroxisome (N  arrow);  the  rest 
correspond to extensively extracted particles or ghosts (arrows).  96.7  •  3.9% of peroxisomal sections was 
found extracted in micrographs from treated rats after this fractionation procedure. The average diameter 
of peroxisomal sections after treatment, in this and other micrographs, is 0.69 •  0.21 #m, no different from 
the  value  for  proliferated particles  fixed  in  situ  in  the  liver.  A  bile  canaliculus  (BC)  illustrates the 
heterogeneity of this fraction, x  12,000. 
301 FIGURE  24  ML  particulate  fraction  from  a  control  liver  prepared  by  the  multiple-step regular tissue 
fractionation procedure. Many peroxisome sections (arrows) show partial or complete matrix extraction, a 
phenomenon found  in  67.8  -4-  10.8%  of the  peroxisome sections examined in  normal  rats.  The  average 
diameter  of these sections was 0.56  •  0.15 ~am, no different  from  the  average  value found  for  normal 
particles fixed in situ in the liver. Extracted peroxisomes have a continuous membrane and a characteristic 
submembranous localization  of their  residual content;  they  usually correspond  to  the  bigger  particles. 
Normal peroxisomes (N) have the same morphological characteristics of normal particles in tissue sections. 
￿  14,000. 
302 FIGURE  25  ML particulate fraction from the liver of a rat treated for 6.5 days with Su-13437 prepared as 
the  fraction  shown  in  Fig.  24.  Only  extracted  peroxisomes,  or  ghosts, can  be  seen  (arrows).  Normal 
peroxisomes were  never found in ML pellets from treated  rats.  In some particles (P arrows), a  clump of 
electron-dense material, reminiscent of the nucleoid, adheres to the inner side of the membrane. The aver- 
age diameter of extracted peroxisomes, or ghosts, was found to be 0.69 +  0.18 ~m, no different from the 
value for proliferated particles fixed in situ, in the liver,  x  14,000. 
303 the  same  time,  particle-bound  catalase  per gram 
liver decreases by one-half. 
The  origin  of the  catalase  normally  present  in 
the supernate has not been established. It could be 
derived  entirely  from  particles  damaged  during 
fractionation (2, 42). According to Lazarow and de 
Duve  (37,  38),  the  enzyme  is  assembled  inside 
peroxisomes;  moreover,  if particle  degradation  is 
due  to  autophagy,  the  enzyme  might  never  be 
present  in  the  cell  sap.  But  there  are  arguments 
supporting the idea that, indeed, some of the liver 
catalase present in the soluble fraction is located in 
vivo outside peroxisomes. 
Several reports on chromatographic and electro- 
phoretic differences between  soluble  and  particle- 
bound catalases  have appeared  (20,  27,  28). They 
can  be questioned  on  the  basis that  the  exposure 
of the enzyme during fractionation to two different 
biochemical  environments,  that  of  the  supernate 
and that of the particulate  fraction, could  lead to 
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FIGURE 26  [*~C]Leucine  incorporation into proteins in 
liver  slices  from  Su-13437-treated  rats.  Deoxycholate- 
soluble protein (filled circles). Catalase immunoprecipi- 
tare (open circles). Each point is the average of four rats. 
Results are expressed as the change percent of the cpm 
per gram liver found in control rats: 251 •  30 ￿  l0  s cpm 
into  DOC-soluble  protein  and  563  •  77  cpm  into 
immunoprecipitable catalase. These values correspond to 
1,375  •  189 cpm per mg DOC-soluble protein and 26.2 
•  2.8 cpm per mg protein of the immunoprecipitate. The 
smaller standard deviation bars at zero time correspond 
to  DOC-soluble protein; for the other points, only one 
standard deviation, over or below the average point, has 
been drawn. The relative incorporation increment after 
1.5  days  is  larger  for  the  catalase  immunoprecipitate 
(0.025  <  P  <  0.050). 
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FIGURE 27  Catalase turnover. Semilogarithmic repre- 
sentation of the changes in activity after various treat- 
ments: allyl isopropyl acetamide (AIA) was used to block 
the synthesis of catalase in control rats (open circles), and 
in  rats  that had  received  Su-13437  for  3.5  days  (filled 
circles). The  broken line represents turnover of soluble 
catalase in rats treated with Su-13437.  It corresponds to 
the log of the difference in units with the maximal soluble 
activity which is the value obtained after 6.5 days.  All 
points are the average of four rats.  The half-life values 
for catalase, calculated from the functions and equivalent 
to the slope of the lines,  are show in Table V. 
TABLE  V 
Hall-Lives  Calculated for Peroxisomal  Enzymes  and Induced Soluble Catalase 
Half-life  95% confidence interval  n* 
o-Amino acid oxidase 
L-Alpha-hydroxy acid oxidase 
U rate oxidase 
Su- 13437-induced  soluble cataluse 
Total catalase, control, AlAS 
Total catalase, Su- 13437, AIA 
dal;s 
1.25  ( 1.05-1.53)  30 
1.09  (0.93-1.31)  26 
1.13  (0.76-2.21)  18 
1 56  ( 1.29-1.97)  20 
1.27  ( 1.14-1.43)  16 
1.43  (1.23-1.72)  16 
* Number of separate determinations from which the values were derived. 
:~ AIA, allyl isopropyl acetamide. 
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FIGURE 28  Turnover of peroxisomal oxidases during 
Su-13437 administration.  Semilogarithmic  representa- 
tion of the change in activity to a new, lower steady state 
level reached after 6.5 days. L-alpha-hydroxy acid oxi- 
dase  (filled circles). Urate  oxidase (squares).  For  D- 
amino acid oxidase (open circles), the value after 6.5 days 
was considered to  be zero. 10 animals for the control 
points, and 4 for each determination  under treatment. 
Broken lines are extrapolations to facilitate comparisons. 
The half-life values calculated from these data are shown 
in Table V. For the graphic representation, urate oxidase 
units were multiplied by 102 and the rest by 103  . 
selective  modifications  and  the  artifactual  pro- 
duction of two  populations. However,  by in vivo 
tagging  of  the  catalase  molecule  with  3-amino- 
1,2,4-triazole  in  normal  rats,  we  have  found  a 
faster rate of inactivation for the soluble enzyme 
and a selective increase in the rate of inactivation 
of the particulate fraction after administration of a 
peroxisomal oxidase  substrate (N.  Inestrosa  and 
F.  Leighton, unpublished observations). This ob- 
servation can hardly be explained unless catalase, 
in  vivo,  is  present  in  two  compartments.  Our 
results,  as  discussed  below,  are  interpreted  as 
indicating that the large increase in soluble activity 
after  Su-13437  corresponds  to  enzyme  released 
from damaged  particles.  However,  the  induction 
by  the  drug  of  a  large  increase  in  a  normally 
present  nonperoxi~omal  catalase  fraction,  ac- 
counting for  some  of the  increase in the  soluble 
fraction, cannot be entirely ruled out. 
Besides  catalase,  L-alpha-hydroxy acid oxidase 
and  D-amino acid  oxidase  distributions are  also 
affected by Su-13437: in all cases, the supernatant 
fraction is approximately doubled (Fig.  19, Table 
I).  However,  the  fraction  initially present  in the 
supernate is different for each enzyme, if particle 
breakage  with  complete  release  of  contents  is 
responsible for  supernate activities, all peroxiso- 
mal  enzymes  should  be  distributed equally.  We 
have shown previously (43) that damage to peroxi- 
somes by freezing and thawing in 0.25  M  sucrose 
is, in fact, followed  by a gradual and simultaneous 
or parallel release of their enzymes. Since this is 
not  the  case,  some  selectivity  factor  must  be 
involved in their release. 
The mechanical resistance of proliferated perox- 
isomes,  under  homogenization conditions where 
the exposure to, or the magnitude of shear forces 
was greatly increased, was not significantly differ- 
ent  from  that  of the  controls. Thus,  simple me- 
chanical fragility of the particles does not seem to 
be the explanation for the soluble fractionation of 
peroxisomal enzymes. Yet, we show that a normal 
tissue fractionation procedure, the preparation of 
an ML fraction which  involves repeated centrifu- 
gation  and  resuspension  to  wash  and  sediment 
organelles, will selectively decrease the amount of 
particle-bound catalase  when compared  with  the 
single-step fractionation.  Since  peroxisomes  are 
highly  sensitive  to  hydrostatic  pressure  damage 
(12),  this factor, rather than the mechanical stress 
resulting from the resuspension of the pellet during 
the  ML  preparation,  could  explain  the  extra 
release  of  catalase.  Proliferated  peroxisomes 
would be even more sensitive to hydrostatic pres- 
sure, a hypothesis that can be easily explored. This 
would account for the fact that the  28.5%  of the 
catalase  bound  to  proliferated  peroxisomes  de- 
creases  to  11,8 when the  simplified fractionation 
procedure  is  replaced by the complete fractiona- 
tion. For control rats, the extra release under these 
conditions is smaller. 
The morphological aspect of peroxisomes after 
fractionation is very different from  their appear- 
ance when fixed in situ in liver cells. Their average 
diameter  does  not  change,  but  the  matrix  is 
obviously extracted. A fixation artefact, with pro- 
teins being removed  from  a  previously damaged 
particle, might explain the extraction; however, we 
are inclined to believe that the extraction precedes 
fixation: the  ML  fraction from  treated  rats con- 
tains only 5% more liver protein than the controls 
(Fig.  21).  It  can  be  calculated  that  this  extra 
protein  accounts for  the  increase  in cytochrome 
oxidase  and  a  maximum  two-  to  three-fold  in- 
crease  in  peroxisomes,  but  probably  less,  since 
some  protein  should  also  be  assigned  to  the 
additional contamination resulting from  prolifer- 
ated  endoplasmic reticulum.  Baudhuin et  al.  (2) 
have also found a correlation between the extrac- 
tion of matrix and the release of soluble peroxiso- 
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accurate morphometric study, a  fixation artefact 
as  the  explanation  of  the  formation  of  ghosts 
cannot be rejected completely. But,  on the whole, 
our results favor the interpretation that cell  frac- 
tionation procedures damage the particles, causing 
a  partial  release  of their contents to  the  soluble 
fraction and the  formation of ghosts or partially 
emptied peroxisomes. 
The difference observed in the proportion of the 
various peroxisomal enzymes present in the soluble 
fraction  could  be  attributed  to  a  sieving effect 
resulting from  a  differential permeability of the 
peroxisomal membrane to the organelle enzymes, 
a situation similar to that found for red blood cells 
subjected to osmotic stress (46). 
The morphologic extraction of peroxisomes that 
we  describe  is  also  present  in  the  organelles 
prepared  by others  (2,  14), and  should  be  taken 
into  account  when  studying  the  localization  of 
enzymes  within  peroxisomes  from  different  cell 
types (11,  30). 
The peroxisomal membrane is  the  most likely 
target  for  the  postulated  fractionation  damage 
leading to extracted  peroxisomes.  It  is known to 
have  peculiar properties that  could explain their 
selective damage.  Its lability to hydrostatic pres- 
sure  has  been  mentioned;  also,  it  has  a  high 
permeability to sucrose (2) and to the substrates of 
all peroxisomal enzymes (16),  a characteristic not 
shown by other cell membranes. 
The  appearent  permeability to  proteins of the 
peroxisomal  membrane  leads  to  the  conclusion 
that  isolation  of  intact  proliferated  peroxisomes 
from particulate fractions such as those shown in 
this work  is not possible. In fact,  Hess et al. (25) 
were  not able to  isolate peroxisomes proliferated 
after CPIB treatment. They found that the organ- 
elles were  more  labile and equilibrated at  lower 
densities than the controls. 
The  apparent  high  permeability of the  perox- 
isomal  membrane  could  explain  certain  experi- 
mental  findings  and  suggests  a  more  complex 
organization  for  the  particle  in  vivo:  isocitric 
dehydrogenase,  NADP  linked,  was  found  to  be 
localized  in  peroxisomes,  mitochondria, and  the 
soluble fraction of rat liver (4); perhaps part of the 
soluble enzyme is, in fact, peroxisomal. Carnitine 
acyl  transferase  is  another enzyme shown  to  be 
partially  located  in  peroxisomes  from  rat  liver 
(47);  it  also  could  be  more  concentrated  in  the 
organelle than the  fractionation data allow us to 
calculate. 
Turnover of Peroxisomal Enzymes 
The turnover measurements illustrated in Figs. 
27 and 28 and summarized in Table V lead to one 
general conclusion: total  liver catalase in control 
and  treated  rats,  and  soluble catalase,  D-amino 
acid  oxidase,  L-alpha-hydroxy acid  oxidase,  and 
urate oxidase from treated rats have a half-life of 
approximately  1.3  days.  It  had  been  previously 
found (52) that all peroxisomal proteins turn over 
at the same rate, a result later questioned by Poole 
(51) after measuring the kinetic parameters of the 
leucine pool  from  rat  liver.  The  present findings 
allow us to reassert the original conclusion, but on 
a different type of evidence. The conclusion does 
not  agree  with  the  correlation,  established  by 
Dehlinger  and  Schimke  (19)  and  others  (60), 
between the size and the relative rates of degrada- 
tion of proteins. In fact, we have shown previously, 
on Sephadex G-200, that the molecular weight of 
peroxisomal proteins is heterogeneous (43). Thus, 
our findings are compatible with random degrada- 
tion of peroxisomes by autophagy. 
The  equations  we  have  used  to  measure  the 
turnover have been applied assuming steady state 
conditions, i.e. that enzyme synthesis equals degra- 
dation. In practice this was not so, but we did not 
introduce  corrections  because  of  the  difficulties 
involved in establishing accurately the liver growth 
function. This simplification is routinely made in 
turnover studies carried out in growing rats (55). 
The diluting effect  of the  increase in tissue mass 
should  result  in  an  underestimation of  the  real 
values; still, those values we found for catalase are 
approximately the same as those calculated for the 
enzyme with  methods that  minimize overestima- 
tion due to the reutilization of labeled precursors 
(51,  52). 
The  half-life  observed  for  the  supernate,  or 
soluble catalase  according to  the  complete  frac- 
tionation, the same as for the rest of the markers, 
is difficult to interpret. On the whole,  it reflects the 
rate  at  which  the  process  responsible  for  the 
increased levels of catalase appears. Since it is the 
same as for the other enzyme changes, it seems to 
be linked to the proliferated peroxisomes and not 
to a direct or pharmacological effect of the drug on 
the membranes. The measurement probably repre- 
sents the turnover rate  of the peroxisomal mem- 
brane  or  of  its  components  responsible  for  the 
peculiar permeability. This  interpretation, based 
on the hypothesis that the membrane from prolif- 
erated particles is more permeable, does not take 
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volume  ratio of the extracted  peroxisomes. 
Since the half-life of peroxisomal proteins does 
not change, the proliferation should be the result of 
an  increased  rate of synthesis.  In fact,  a  transient 
but  marked  increase  in  the  rate  of  synthesis  of 
catalase  was  detected  upon  measuring  leucine 
incorporation  into  immunoprecipitable  catalase. 
The determinations were  made  with a  crude anti- 
serum,  and  thus  are  subject  to  various  artefacts 
that  should  be considered:  as  stated  in  Materials 
and  Methods,  we  indirectly  discard  nonspecific 
precipitation,  since  no  label  was  found  in  the 
immunoprecipitate  of  partially  hepatectomized 
rats.  From the values we  report  for protein  in the 
immunoprecipitate,  an  average  310  •  52  #g  per 
unit  of  catalase,  and  from  what  has  been  found 
previously  with  purified  catalase  and  purified 
antiserum (43), only about one-half of the precipi- 
tate  can  be  attributed  to  catalase.  Most  of  the 
remaining  protein  could  correspond  to  catalase 
precursors  without  enzymatic  activity  (37).  The 
relative  increments  in  specific  activity  for  the 
immunoprecipitable  material,  and  for  DOC-solu- 
ble  proteins,  correlate  well  with  the  steady  state 
induced  levels  for  catalase  and  for  liver  size.  In 
marked contrast to the results for catalase and for 
the bulk of liver proteins, it can be deduced that the 
rate of synthesis of the oxidases decreases approxi- 
mately  by  50%  and  70%  for  urate  oxidase  and 
L-alpha-hydroxy  acid  oxidase  and  by  practically 
100%  for  D-amino  acid  oxidase.  This property  of 
Su-13437  also  makes  it  a  valuable  tool  for  the 
study  of  the  biological  role  of  D-amino  acid 
oxidase. 
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